| RS1173478186 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1173479131 |
STRA6
|
Health Risk |
Likely pathogenic |
— |
| RS1173482035 |
UBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile-onset X-linked spinal muscular atrophy, Inborn genetic diseases |
| RS1173483373 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS1173494063 |
CUL7
|
Health Risk |
Likely pathogenic |
3-M syndrome, 3-M syndrome |
| RS1173495538 |
MYOT
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 3, Myofibrillar myopathy 3 |
| RS117350233 |
ATP2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brody myopathy, ATP2A1-related disorder |
| RS1173504533 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome |
| RS1173511942 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS1173514495 |
LAS1L
|
Health Risk |
Pathogenic |
Wilson-Turner syndrome, Wilson-Turner syndrome |
| RS1173518955 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1173523308 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS1173532574 |
CHRNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
CHRNB1-related disorder, Congenital myasthenic syndrome 2A |
| RS117356004 |
ACADS
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of butyryl-CoA dehydrogenase, Deficiency of butyryl-CoA dehydrogenase |
| RS1173575355 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS1173576141 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS1173578471 |
GABRA1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS117358479 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, DICER1-related tumor predisposition |
| RS1173590589 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1173594490 |
GYG1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease XV, Polyglucosan body myopathy type 2 |
| RS1173600555 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1173602413 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS117360770 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS1173610818 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrin deficiency, Citrin deficiency |
| RS1173617248 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1173623580 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1173631586 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS1173649955 |
PEX16
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, Inborn genetic diseases |
| RS1173663404 |
FANCL
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1173681603 |
IGF1R
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Growth delay due to insulin-like growth factor I resistance |
| RS1173685095 |
COL4A3;MFF-DT
|
Health Risk |
Likely pathogenic |
— |
| RS1173704265 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS117370446 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 4 |
| RS1173705310 |
RLBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Newfoundland cone-rod dystrophy, Retinitis pigmentosa |
| RS1173707321 |
DHCR7
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS1173716957 |
HHAT
|
Health Risk |
Pathogenic |
Chondrodysplasia-pseudohermaphroditism syndrome, Chondrodysplasia-pseudohermaphroditism syndrome |
| RS1173722715 |
ABCA12
|
Health Risk |
Pathogenic |
— |
| RS1173733121 |
ETFB
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS1173748968 |
F11
|
Health Risk |
Pathogenic |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS1173771882 |
AEBP1
|
Health Risk |
Pathogenic |
— |
| RS1173779851 |
OTOGL
|
Health Risk |
Pathogenic |
— |
| RS1173818227 |
FANCI
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group I |
| RS117382379 |
TTBK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 11, Inborn genetic diseases |
| RS1173826571 |
AARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1173829042 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1173833392 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1173853484 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1B |
| RS117385606 |
GJB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness, digenic |
| RS1173889040 |
IPO8
|
Health Risk |
Pathogenic |
VISS syndrome, VISS syndrome |
| RS1173899198 |
MARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency, Charcot-Marie-Tooth disease axonal type 2U |
| RS117390152 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
DCHS1-related disorder, DCHS1-related disorder |
| RS117390537 |
MYH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, proximal |
| RS1173940446 |
SDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1173941971 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS1173945551 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
GNE myopathy, Sialuria |
| RS11739468 |
HSD17B4
|
Health Risk |
Conflicting classifications of pathogenicity |
Perrault syndrome 1, Bifunctional peroxisomal enzyme deficiency |
| RS117394753 |
PSEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alzheimer disease 3, Dilated cardiomyopathy 1U |
| RS1173948061 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS11739510 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS117400534 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS117400594 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCA4-related disorder, Retinal dystrophy |
| RS1174006665 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS1174011798 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1174023229 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1174027832 |
VPS33B
|
Health Risk |
Pathogenic |
— |
| RS1174029281 |
BEST1
|
Health Risk |
Pathogenic |
— |
| RS1174029388 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1174034398 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS1174034883 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1174042673 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 26 |
| RS1174052172 |
ODAD1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 20, Primary ciliary dyskinesia 20 |
| RS1174060268 |
HLCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS1174065588 |
DRC4
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 33, Primary ciliary dyskinesia 33 |
| RS1174079177 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1174104045 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS117411391 |
OTOGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 84B, Autosomal recessive nonsyndromic hearing loss 84B |
| RS1174120641 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1174121102 |
BCKDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS1174122105 |
ABCA12
|
Health Risk |
Pathogenic |
— |
| RS1174145893 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS117419007 |
CCDC40
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 15 |
| RS1174193938 |
RP1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 1, Retinitis pigmentosa |
| RS1174222059 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS1174225838 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS117422805 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1174228917 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS1174232828 |
ECEL1
|
Health Risk |
Likely pathogenic |
Distal arthrogryposis type 5D, Distal arthrogryposis type 5D |
| RS117423374 |
IL10RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inflammatory bowel disease 28, Inflammatory bowel disease 28 |
| RS117423733 |
POGLUT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1174255706 |
VRK1
|
Health Risk |
Pathogenic |
Pontoneocerebellar hypoplasia, Pontoneocerebellar hypoplasia |
| RS1174260635 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1174268388 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1174270999 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1174303167 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1174316105 |
SYNE1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS1174331239 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS1174332682 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS117433399 |
LAMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA1-related disorder, LAMA1-related disorder |
| RS1174344987 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1174348338 |
KCNQ3
|
Health Risk |
Pathogenic |
Benign neonatal seizures, Benign neonatal seizures |